BioMaxima S.A. (BMX.WA)
PLN 12.75
(3.24%)
PLN 12.75
(3.24%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.28 Million PLN | -95.17% |
| 2022 | 38.36 Million PLN | 151.67% |
| 2021 | 14.77 Million PLN | 33.99% |
| 2020 | 11.41 Million PLN | 346.68% |
| 2019 | 2.45 Million PLN | 69.47% |
| 2018 | 1.2 Million PLN | -51.74% |
| 2017 | 3.08 Million PLN | -3.87% |
| 2016 | 3.31 Million PLN | -6.46% |
| 2015 | 3.47 Million PLN | 36.52% |
| 2014 | 2.53 Million PLN | -20.74% |
| 2013 | 3.42 Million PLN | 8.23% |
| 2012 | 3.5 Million PLN | 56.76% |
| 2011 | 1.88 Million PLN | 61.62% |
| 2010 | 1.14 Million PLN | -0.89% |
| 2009 | 1.17 Million PLN | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 860 Thousand PLN | 127.62% |
| 2024 Q2 | 677 Thousand PLN | -41.02% |
| 2023 Q3 | 111 Thousand PLN | -92.48% |
| 2023 FY | - PLN | -95.17% |
| 2023 Q1 | 1.1 Million PLN | 12.07% |
| 2023 Q2 | 1.47 Million PLN | 33.67% |
| 2023 Q4 | 583 Thousand PLN | 425.23% |
| 2022 FY | - PLN | 151.67% |
| 2022 Q1 | 31.23 Million PLN | 710.46% |
| 2022 Q2 | 4.44 Million PLN | -85.77% |
| 2022 Q3 | 1.65 Million PLN | -62.69% |
| 2022 Q4 | 986 Thousand PLN | -40.57% |
| 2021 Q4 | 3.85 Million PLN | 97.24% |
| 2021 Q1 | 8.42 Million PLN | 89.62% |
| 2021 Q2 | 1.2 Million PLN | -85.72% |
| 2021 FY | - PLN | 33.99% |
| 2021 Q3 | 1.95 Million PLN | 62.43% |
| 2020 Q4 | 4.44 Million PLN | 147.29% |
| 2020 Q2 | 4.23 Million PLN | 349.32% |
| 2020 Q1 | 943.02 Thousand PLN | -20.7% |
| 2020 FY | - PLN | 346.68% |
| 2020 Q3 | 1.79 Million PLN | -57.59% |
| 2019 FY | - PLN | 69.47% |
| 2019 Q1 | 364.36 Thousand PLN | 192.71% |
| 2019 Q2 | 475.14 Thousand PLN | 30.41% |
| 2019 Q3 | 550.6 Thousand PLN | 15.88% |
| 2019 Q4 | 1.18 Million PLN | 115.97% |
| 2018 Q2 | 942.34 Thousand PLN | 48.85% |
| 2018 FY | - PLN | -51.74% |
| 2018 Q1 | 633.08 Thousand PLN | -22.06% |
| 2018 Q3 | -198.46 Thousand PLN | -121.06% |
| 2018 Q4 | 124.48 Thousand PLN | 162.72% |
| 2017 FY | - PLN | -3.87% |
| 2017 Q2 | 631.93 Thousand PLN | -27.39% |
| 2017 Q1 | 870.36 Thousand PLN | -16.09% |
| 2017 Q4 | 812.27 Thousand PLN | -7.27% |
| 2017 Q3 | 875.93 Thousand PLN | 38.61% |
| 2016 Q1 | 968.58 Thousand PLN | 2.73% |
| 2016 Q4 | 1.03 Million PLN | 74.9% |
| 2016 Q3 | 593.06 Thousand PLN | -6.99% |
| 2016 Q2 | 637.61 Thousand PLN | -34.17% |
| 2016 FY | - PLN | -6.46% |
| 2015 Q2 | 801.29 Thousand PLN | -13.55% |
| 2015 FY | - PLN | 36.52% |
| 2015 Q1 | 926.91 Thousand PLN | 54.69% |
| 2015 Q4 | 942.8 Thousand PLN | 19.47% |
| 2015 Q3 | 789.15 Thousand PLN | -1.51% |
| 2014 Q3 | 340.16 Thousand PLN | -50.87% |
| 2014 Q2 | 692.44 Thousand PLN | -22.55% |
| 2014 Q1 | 894.04 Thousand PLN | 14.13% |
| 2014 Q4 | 599.21 Thousand PLN | 76.15% |
| 2014 FY | - PLN | -20.74% |
| 2013 Q3 | 977.32 Thousand PLN | 17.96% |
| 2013 Q4 | 783.33 Thousand PLN | -19.85% |
| 2013 FY | - PLN | 8.23% |
| 2013 Q1 | 677.7 Thousand PLN | -66.73% |
| 2013 Q2 | 828.5 Thousand PLN | 22.25% |
| 2012 Q1 | 371.58 Thousand PLN | 0.0% |
| 2012 FY | - PLN | 56.76% |
| 2012 Q2 | 305.3 Thousand PLN | -17.84% |
| 2012 Q4 | 2.03 Million PLN | 938.41% |
| 2012 Q3 | 196.14 Thousand PLN | -35.75% |
| 2011 FY | - PLN | 61.62% |
| 2010 FY | - PLN | -0.89% |
| 2009 FY | - PLN | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Scope Fluidics S.A. | -17.24 Million PLN | 119.041% |
| Selvita S.A. | 125.61 Million PLN | 97.386% |
| Voxel S.A. | 152.85 Million PLN | 97.852% |